[Beta-blockers in the prevention of the rupture of esophageal varices. A meta-analysis]
- PMID: 1364274
[Beta-blockers in the prevention of the rupture of esophageal varices. A meta-analysis]
Abstract
The meta-analysis of 5 trials for primary prevention and of 18 trials of secondary prevention emphasizes the effect of beta-blockers in the decrease of variceal bleedings in cirrhosis. Beta-blockers are reducing the bleeding events with 32% in the primary prevention and with 28% in the secondary prevention. The mortality is reduced by 15%, respectively by 23%. This is the first meta-analysis reported in the Romanian gastroenterological literature.
Similar articles
-
Meta-analysis: endoscopic variceal ligation for primary prophylaxis of oesophageal variceal bleeding.Aliment Pharmacol Ther. 2005 Feb 15;21(4):347-61. doi: 10.1111/j.1365-2036.2005.02346.x. Aliment Pharmacol Ther. 2005. PMID: 15709985 Review.
-
Beta-blockers for the prevention of variceal haemorrhage in patients with cirrhosis: an updated meta-analysis of randomized controlled trials.Ital J Gastroenterol. 1991 Sep-Oct;23(7):408-15. Ital J Gastroenterol. 1991. PMID: 1683803
-
Beta-blockers in the prevention of gastrointestinal bleeding.Rev Invest Clin. 1990 Jul;42 Suppl:159-64. Rev Invest Clin. 1990. PMID: 19256157 Review.
-
Beta-blockers for prophylaxis of bleeding from esophageal varices in cirrhotic portal hypertension. Review of the literature.Eur J Med Res. 1996 Jun 25;1(9):407-16. Eur J Med Res. 1996. PMID: 9353240 Review.
-
Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multicenter Study Group.N Engl J Med. 1991 May 30;324(22):1532-8. doi: 10.1056/NEJM199105303242202. N Engl J Med. 1991. PMID: 1674104 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical